0001437749-23-000883.txt : 20230111 0001437749-23-000883.hdr.sgml : 20230111 20230111164325 ACCESSION NUMBER: 0001437749-23-000883 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230111 DATE AS OF CHANGE: 20230111 EFFECTIVENESS DATE: 20230111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Luminary Therapeutics, Inc. CENTRAL INDEX KEY: 0001793860 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-470421 FILM NUMBER: 23524027 BUSINESS ADDRESS: STREET 1: 1621 E. HENNEPIN AVENUE STREET 2: SUITE 290 CITY: MINNEAPOLIS STATE: MN ZIP: 55414 BUSINESS PHONE: 612-309-7653 MAIL ADDRESS: STREET 1: 1621 E. HENNEPIN AVENUE STREET 2: SUITE 290 CITY: MINNEAPOLIS STATE: MN ZIP: 55414 D 1 primary_doc.xml X0708 D LIVE 0001793860 Luminary Therapeutics, Inc. 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 612-309-7653 DELAWARE None None Corporation true 2019 Jeff Liter 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Executive Officer Director Promoter John Hurley 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Executive Officer David Largaespada 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Promoter John Wells 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director James Haymaker 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Tracey Lodie 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director George Cox 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Mark Chance 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Peter Kosa 1200 Washington Avenue South Suite 260 Minneapolis MN MINNESOTA 55415 Director Biotechnology Decline to Disclose 06b false 2022-09-28 false true true SAFE (Simple Agreement Future Equity) false 0 2750000 2154500 595500 false 10 0 0 0 false Luminary Therapeutics, Inc. /s/ Jeff Liter Jeff Liter President and Chief Executive Officer 2023-01-11